Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Explore the value of credit card points when converted to cash to maximize your returns. Learn how to make your points work for you.
25,460 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
During this June trading session, the Dow surged to a new peak even as technology names faced pressure. This article ...
Walmart is turning growth from stores to a digital revenue engine. Advertising, memberships, and a thriving marketpla...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
Biotech investing often rides on data, not on dreams. This educational piece uses a fictional company to show how wal...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
A prominent investor dumped $6.5 million of SentinelOne stock as the cybersecurity firm’s shares fell sharply. This a...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
The market spotlight shifted to united states antimony stock after a notable insider purchase sparked a rally. This a...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
Insider moves can shed light on a company’s trajectory, but they aren’t a crystal ball. This guide breaks down biotec...
Adobe stock is back in the spotlight as AI reshapes software. This guide explains what drives the buzz, how Adobe ear...